A new pill form of the weight-loss medication Wegovy has been approved for use in the UK, offering a potentially more accessible and affordable alternative to its injectable counterpart. The pill contains semaglutide, the same appetite-suppressing ingredient found in the Wegovy injection, and is part of a new class of weight-loss treatments that have gained significant traction. In the U.S., where the pill has been available since January, patients have reported substantial weight loss. For example, Rebecca Walker, 47, from Nevada, stated she lost over 15 pounds in two months. David Clarke, 40, from New York, reported a 5-pound loss in just three weeks.
The Wegovy pill is expected to see high demand, with online pharmacies in the UK reporting waiting lists exceeding 100,000 patients. This surge in interest is partly attributed to a preference for oral medication over injections; recent polling suggests twice as many patients would opt for a pill. ## Accessibility and Cost The Wegovy pill will be available through private clinics, though its availability on the National Health Service (NHS) remains uncertain. The manufacturer, Novo Nordisk, is reportedly in discussions with the UK government regarding an NHS rollout, with pricing being a significant consideration. Patients must meet a BMI of 30 or above, or a BMI between 27 and 30 with a weight-related condition, to be eligible. Experts anticipate the pill will be more affordable than the injections. In the U.S., a month's supply of the highest 25mg dose costs approximately $225 (£175), compared to around $260 (£203) for the injections, a saving of roughly $35 (£28). This cost difference is largely due to the lower production costs of pills compared to injections. However, some UK providers are listing the pill at the same price as the injections, around £199 per month. The pill is expected to be significantly cheaper than rival jab Mounjaro, which typically costs about £300 per month. ## Efficacy and Usage Studies indicate that patients using the Wegovy pill lose an average of 14% of their body weight, compared to approximately 15% for those using the injections. While the difference is minimal, the pill may be perceived as less intense initially. However, it is less potent than Mounjaro, associated with an average weight loss of around 20%. The effectiveness of the Wegovy pill is dependent on adherence to specific instructions: it must be taken with a small glass of water after an eight-hour fast, and patients must avoid eating for 30 minutes afterward to ensure proper absorption and appetite-suppressing effects. Patients report that this routine is manageable. ## Side Effects and Weight Management The side effects of the Wegovy pill are generally consistent with the injections, though some users report them being milder. Common side effects include nausea, vomiting, diarrhea, constipation, bloating, heartburn, fatigue, and dizziness. These symptoms often occur when starting the medication or increasing the dose, and usually subside within a few weeks. In rare instances, pancreatitis can occur. Experts emphasize that diet plays a crucial role in maximizing the benefits of the medication and for long-term weight management. Some patients do not achieve significant weight loss, and up to 85% may experience a plateau. Furthermore, research suggests that two-thirds of patients regain lost weight after discontinuing the drug, highlighting the need for sustainable lifestyle changes. Health professionals recommend overhauling dietary habits while on the treatment, focusing on protein and fiber-rich foods. Natural protein sources such as vegetables, lean meats, and pulses, along with fiber from fruits, nuts, and seeds, can help maintain muscle mass and promote satiety. There is also emerging evidence that omega-3 fatty acids, found in oily fish and nuts, may enhance the body's production of the GLP-1 hormone. Patience is also advised, as weight loss can take time, particularly at lower doses.